Pain Therapeutics Inc.
2211 Bridgepointe Parkway
Suite 500
San Mateo,
CA 94404
United States - Map
Phone: 650-624-8200
Fax: 650-624-8222
Web Site: http://www.paintrials.com
| Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of novel drugs. It has four drug candidates in clinical development programs, which include Remoxy, a novel controlled-release oral capsule form of oxycodone; PTI-202 and PTI-721, which are abuse-resistant forms of opioid drugs; and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. The company is also developing a technology for the treatment of hemophilia in patients. Pain Therapeutics, Inc. has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy, PTI-202, PTI-721, and another abuse-resistant opioid painkiller. The company was founded in 1998 and is based in San Mateo, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Remi Barbier , 49
Founder, Chairman, Chief Exec. Officer and Pres |
$
991.00K |
$
0 | Mr. Peter S. Roddy , 49
Chief Financial Officer, Principal Accounting Officer and VP |
$
428.00K |
$
0 | Dr. Nadav Friedmann M.D., 66
Chief Operating Officer, Chief Medical Officer |
$
758.00K |
$
159.00K | Dr. Grant L. Schoenhard Ph.D., 64
Chief Scientific Officer |
$
433.00K |
$
0 | Mr. Michael J. O'Donnell Esq., 50
Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.18% Nasdaq 
0.42%
Profile
